Optimal management of coronary artery disease in very old patients -over eighty years of age -remains unclear due to the absence of large randomized trials in this high-risk subgroup and the benefit/risk ratio of percutaneous coronary intervention (PCI) is difficult to assess in clinical practice.
Background: The incidence and long term prognosis of women presenting troponin positive NSTE-ACS and a normal angiogram is unknown. Aim: To investigate the incidence, characteristics and long term prognosis of women presenting with a NSTEMI and normal coronary angiogram compared to women with NSTEMI and significant coronary artery disease (CAD) on the angiogram.
Methods:
Between 1999 and 2008, we screened patients presenting with an acute coronary syndrome (ACS) to identify those with a positive troponin and a normal angiogram. Extra-cardiac causes of troponin elevation were excluded. Women were matched by age and presence or absence of ST-elevation with a 1:2 ratio, to women with significant CAD. We compared characteristics and outcomes of the two groups of women.
Results: Over 4085 ACS patients, 1581 had a significant elevation of troponin, with 343 women (21.7%) and 1238 men (78.3%). One hundred and twelve patients (7.1 %) had a normal angiogram with a 3-fold higher proportion of women (14.5%; n=50) compared to men (5.0%, n=52); p<0.001. When these women with a normal angiogram were compared with 100 women with significant CAD, they were less likely to have a high peak of troponin (> 5 times the upper limit of normal: 46% vs. 80%, p<0.0001). No other significant difference was found between the two groups. Mean follow-up was 4.3 +/-3.1 years. Women with a normal angiogram had an excellent survival rate of 91.3% compared to 71.2% in women with CAD (p=0.03), they had also a lower readmission rate for cardiovascular reason, (14% vs. 54%, p=0.01).
Conclusion:
Women presenting with NSTEMI who have a normal angiogram, do not differ from women with NSTEMI and angiographic CAD. However, they have a smaller rise of troponin and a much better long-term prognosis.
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Identification of the optimal timing of invasive strategy in acute coronary syndromes: analysis from the ABOARD Study Guillaume Cayla (1), Johanne Silvain (2), Olivier Barthelemy (2), Anne Bellemain-Appaix (2), Farzin Beygui (2), Simon Elhadad (3), Hervé Le Breton (4), Florence Leclercq (5), Jean-Philippe Collet (2), Gilles Montalescot (2) (1) CHU Nîmes, Hopital Caremeau, Service de Cardiologie, Nîmes, France -(2) CHU Pitié Salpêtrière, Institut de cardiologie, INSERM U 937, Paris, France -(3) Hopital Lagny, Cardiologie, Lagny, France -(4) Hopital de Rennes, Cardiologie, Rennes, France -(5) Hopital Arnaud de Villeneuve, Cardiologie, Montpellier, France Aim: To determine the optimal timing of catheterization in high risk acute coronary syndromes.
Methods:
The randomized ABOARD study showed that in patients with acute coronary syndromes without ST-segment elevation, a "primary PCI" strategy compared with a strategy of intervention deferred to the next working day did not result in a difference in clinical outcome. We performed a new analysis of the ABOARD population which was divided into quartiles of time from randomization to catheterization. Like in the main analysis the primary endpoint was the peak troponin value during hospitalization and the key secondary end point was the composite of death, myocardial infarction, or urgent revascularization at 1 month follow-up.
Results:
The population (n=352) was divided into four quartile-groups. In the first quartile, catheterization was performed within the first 69 minutes (median: 50 minutes) after randomization, in the second group between 69 and 339 minutes (median: 118 minutes), in the third one between 339 and 1247 min (median : 1048 minutes) and in the last one over 1247 minutes (median 1448 minutes).
Patients: received intense antiplatelet therapy with a mean 660 mg (±268) loading dose and 111 mg (±40) maintenance dose of clopidogrel while 99% of the PCI patients received abciximab . Low-molecular-weight-heparins were used in 68% of patients and radial approach was predominant (84%).The mean (+/-SD) peak of troponin did not differ between the 4 groups (Q1=7.5 ng/mL± 12.3, Q2=9 ng/mL ± 22.5, Q3 = 7 ng/mL ± 12.3, Q4= 6.4 ng/mL ± 13.5) p= 0.66). The 30-day rate of death, myocardial infarction and urgent revascularization did not differ between the four groups. (Q1=20%) (23%), Q2= 20 The coronarography was performed in 69% of cases for acute coronary syndrome, assessment of stable angina in 32% of cases. Two-vessel coronary artery disease was noted in 20% of patients and Three-vessel disease represented 35% of cases. Drug-eluting stents were used in 60% of cases, 10% of coronary artery bypass graft. We noted six deaths, including 2 postoperative.
Conclusion:
Coronary artery disease is not only more frequent in diabetics; it is also more severe because of the spread and complexity of coronary lesions, with higher rates of thrombosis and restenosis of stents.
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Invasive arrhythmic assessment after myocardial infarction ; actual results
Béatrice Brembilla-Perrot, Bérivan Azman, Pierre Yves Zinzius, Jérôme Schwartz, Soumaya Jarmouni, Raphaël Pedro Martins, Ibrahim Nossier, Pierre Louis, Olivier Selton, Arnaud Terrier De La Chaise, Hugues Blangy, Nicolas Sadoul CHU of Brabois, Cardiologie, Vandoeuvre Les Nancy, France Programmed ventricular stimulation (PVS) was proposed after myocardial infarction (MI) more than 25 years ago, but the management of MI has changed during this period. The purpose of the study was to look for the results of systematic PVS after MI according to the period of indication and remaining indications.
Methods: PVS was performed between 1982 and march 2010, from 4 to 8 weeks after acute MI in 797 patients (pts) without syncope or ventricular tachycardia (VT) to stratify the risk of arrhythmias: 301 (group I) were studied between 1982 and 1989, 315 (group II) between 1990 and 1999 and 179 (group III) between 2000 and 2010. PVS used the same protocol (up to 3 extrastimuli in 2 sites of right ventricle).
Results: Group III pts were older (61±10 years) than group I (56±11) and group II pts (58±11) (p <0.002). LVEF was lower in group III (36±11%) than in group I (44±15) and II (41±12) (p<0.05). PVS was as frequently negative in group III (58.5 %) as in group I (52 %) and II (47 %). Monomorphic VT < 270 b/min was induced as frequently in group III (27 %) as in group I (20 %) and II (21.5 %). Ventricular fibrillation was induced less frequently in group III (7 %) than in group II (12 %) and I (13 %) (p <0.04). Ventricular flutter (VT > 265 b/min) was induced less frequently in group III (8 %), than in group II (18 %, p< 0.001) and I (15 %) (p < 0.03). The only significant difference was the primary angioplasty with recanalization of occluded coronary artery, more systematic since 2000: total revascularization was obtained in 39 % of group III and 27 % of groups II and I (p <0.05).
Conclusions:
The interpretation of PVS are now easier to interpret, because the induction of non specific arrhythmias, the ventricular flutter and fibrillation, is rarer than before 2000, although PVS was indicated in patients with lower LVEF. The decrease of the induction of this arrhythmia could be related to the more systematic indication of primary angioplasty in MI since 2000. PVS remains useful in pts with debatable indications of defibrillator to help to take a decision.
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The epidemiological profile of Moroccan coronary disease
Fatima Wadrahmane, Hanane Benhalla CHU Ibn Rochd Casablanca, cardiologie, Casablanca, Maroc
Coronary artery disease occupies a special place in cardiovascular diseases in Moroccan population because of its high frequency and mortality.
In this work we propose to study the epidemiological profile, clinical; angiographic;and therapeutic characteristics of Moroccan coronary.
Our study is a retrospective study that included all patients who had a coronarography from 01/01/08 to 30/12/09 in the department of cardiology of Ibn Rochd.
On 846 patients with coronary artery disease male was 66.8%; their mean age was 62.3 years. The cardiovascular risk factors are hypertension in 38.89% of cases, smoking in 34.34% of cases, diabetes mellitus in 30.85% of cases, hypercholesterolemia in 16.67% of cases, age over 75 years in 9.9% of cases, the coronary heredity4.14 of cases.
The coronary disease of Moroccan patient presents by angina stable angina in 35.5% of cases, unstable angina in 7% of cases, crescendo angina in 1.79% of cases, typical chest pain in 9.77% of cases, STEMI in 28.83% of cases, NSTEMI in 16.45% of cases. the silent myocardial ischemia in 0.49% of cases. The ischemia was documented on ECG changes in 42.54% of cases, on myocardial scintigraphy in 6.83% of cases, stress test in 9.94 % of cases.
The number of patients with acute coronary syndromes treated in the first 24 hours is 61.43%, between D7 and D21 around 4.29%, after 21 days in 5% of cases, and after one month 11.43% of patients. The ejection fraction on admission was greater than 50% in 51.31%, 41 -50% in 23.86%, 30-40% in 15.3% of cases, less than 30% in 9.8% of cases.
The management of coronary syndrome in our center was thrombolysis in 63.33 % of cases, primary angioplasty in 13.33% with a drug-eluting stent used in 33.3% of all angioplasty.
In Morocco the rate of primary angioplasty remains insufficient and does not meet the recommendations of the acute coronary syndrome. This epidemiological study is the first step of the long path to optimize the management of Moroccan coronary disease.
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Coronary thrombectomy: technical comparison of two systems on a laboratory bench. Impact of bends, angles and thrombus age.
Luc Lorgis (1), Virginie Pioud (2), Bernard Collin (3), Nathalie Garnier (2), Marie Pierre Guenfoudi (2), Carole Richard (1), Marianne Zeller (3), Claude Touzery (1), Marie Hélène Guignard (2), Luc Rochette (3), Yves Cottin (1) (1) CHU Bocage, Cardiologie, Dijon, France -(2) CHU Bocage, Pharmacie, Dijon, France -(3) IFR 100 santé-STIC, LPPCE, Dijon, France Background: Despite the results of recent randomized studies, the systematic use of aspiration techniques in ST-elevation myocardial infarction has not been included in the new guidelines. To date, there have been very few bench tests of the different systems and the aim of our study was to test two catheters on different models of arteries with 6 and 12-hour-old thrombi.
